DB05716ExperimentalProtein Based Therapies
ICX-RHY is an investigational therapy comprised of cultured allogeneic fibroblasts. The drug was under investigation in clinical trials in the UK for the treatment of skin erosions in recessive dystrophic...
- Primary indication
- Investigated for use/treatment in skin infections/disorders.Curator reviewed
- Also known as
- Vavelta
What you can answer from here — as of April 02, 2025
Which companies are running trials of ICX-RHY, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account